the aim of the present study was to assess the clinical efficacy and safety of a new h2-antagonist , nizatidine ( n ) , administered as a single bedtime dose of 300 mg , compared with ranitidine ( r ) at the same dosage , in the short-term treatment of duodenal ulcer .
C0085154
nizatidine
C0013295
duodenal ulcer